Fig. 8: Si-Hspb1 in combination with RT and IO enhanced T-cell-mediated anti-tumor immunity in vivo. | Genes & Immunity

Fig. 8: Si-Hspb1 in combination with RT and IO enhanced T-cell-mediated anti-tumor immunity in vivo.

From: Radiotherapy combined with anti-PD-1 immunotherapy promotes ferroptosis-driven control of hepatocellular carcinoma

Fig. 8

Flow cytometry analyses of the populations of (A) CD3 + CD8a + , B CD8a+ IFN-γ + , C CD4 + CD44 + CD62L- and D CD8a + CD44 + CD62L- T cells in the peripheral blood samples from Hepa1-6 tumor-bearing mice. *P < 0.05, **P < 0.01, ***P < 0.001.

Back to article page